Danaher Corporation (DHR) : Aspiriant scooped up 571 additional shares in Danaher Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 9, 2016. The investment management firm now holds a total of 36,158 shares of Danaher Corporation which is valued at $2,948,323.Danaher Corporation makes up approximately 0.25% of Aspiriant’s portfolio.
Other Hedge Funds, Including , Essex Financial Services reduced its stake in DHR by selling 42 shares or 0.83% in the most recent quarter. The Hedge Fund company now holds 5,012 shares of DHR which is valued at $408,177. Danaher Corporation makes up approx 0.10% of Essex Financial Services’s portfolio.Seaward Management Limited Partnership reduced its stake in DHR by selling 4,027 shares or 4.19% in the most recent quarter. The Hedge Fund company now holds 92,196 shares of DHR which is valued at $7,454,047. Danaher Corporation makes up approx 0.40% of Seaward Management Limited Partnership’s portfolio.Ls Investment Advisors boosted its stake in DHR in the latest quarter, The investment management firm added 3,070 additional shares and now holds a total of 193,670 shares of Danaher Corporation which is valued at $15,733,751. Danaher Corporation makes up approx 1.05% of Ls Investment Advisors’s portfolio.Reinhart Partners reduced its stake in DHR by selling 330 shares or 9.57% in the most recent quarter. The Hedge Fund company now holds 3,120 shares of DHR which is valued at $253,469. Danaher Corporation makes up approx 0.02% of Reinhart Partners’s portfolio.
Danaher Corporation opened for trading at $80.82 and hit $81.05 on the upside on Wednesday, eventually ending the session at $81.02, with a gain of 0.40% or 0.32 points. The heightened volatility saw the trading volume jump to 16,06,048 shares. Company has a market cap of $55,947 M.
On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.